Why MBX Capital is Betting $100M on the Link Between Industrial Toxins and Chronic Disease
What You Should Know: – MBX Capital has secured over $100M in capital commitments to invest in early-stage biotech and health tech companies, specifically focusing on “deep health” solutions that…
Physician-Led Health Tech Startup Scales Therapeutic Plasma Exchange (TPE) Nationwide Amid Rise in Diseases Linked to Toxins
MDLifespan’s patented PlasmaXchange™ protocols remove all environmental toxins from the body which are driving chronic diseases — including the first mold detox removing 90% of mold toxins CHICAGO, July 21,…